Cargando…
Protectin DX Relieve Hyperoxia‐induced Lung Injury by Protecting Pulmonary Endothelial Glycocalyx
BACKGROUND: Bronchopulmonary dysplasia (BPD) is a common chronic lung disease in premature infants with limited treatments and poor prognosis. Damaged endothelial glycocalyx leads to vascular permeability, lung edema and inflammation. However, whether hyperoxia increases neonatal pulmonary microvasc...
Autores principales: | Liang, Zhongjie, Yue, Huilin, Xu, Congcong, Wang, Qian, Jin, Shengwei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9900492/ https://www.ncbi.nlm.nih.gov/pubmed/36755970 http://dx.doi.org/10.2147/JIR.S391765 |
Ejemplares similares
-
Posttreatment with Protectin DX ameliorates bleomycin-induced pulmonary fibrosis and lung dysfunction in mice
por: Li, Hui, et al.
Publicado: (2017) -
Protectin DX Exhibits Protective Effects in Mouse Model of Lipopolysaccharide-Induced Acute Lung Injury
por: Tan, Wen, et al.
Publicado: (2018) -
Protectin DX increases alveolar fluid clearance in rats with lipopolysaccharide-induced acute lung injury
por: Zhuo, Xiao-Jun, et al.
Publicado: (2018) -
Protectin DX as a therapeutic strategy against frailty in mice
por: Perazza, Laís R., et al.
Publicado: (2023) -
Anti-inflammatory and anti-virus potential of poxytrins, especially protectin DX
por: Lagarde, Michel, et al.
Publicado: (2020)